Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Henriksen

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|August 15, 2013
Type VI collagen turnover-related peptides-novel serological biomarkers of muscle mass and anabolic response to loading in young menAnders Nedergaard, Shu Sun, Morten A Karsdal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 6, 2025
Targeting the root cause of obesity-related comorbidities through weight independent and dependent actions on insulin sensitivity: Benefits of dual amylin and calcitonin receptor agonistsAnna Thorsø Larsen, Simone Anna Melander, Khaled Elhady Mohamed, et al.
Journal of Bone and Mineral Metabolism|December 26, 2006
Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral bloodMette Grøndahl Sørensen, Kim Henriksen, Sophie Schaller, et al.
Arthritis and Rheumatism|July 28, 2006
Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiationSvetlana Oestergaard, Bodil C Sondergaard, Pernille Hoegh-Andersen, et al.
The Journal of Biological Chemistry|August 23, 2003
Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expressionMorten A Karsdal, Pernille Hjorth, Kim Henriksen, et al.
Neurochemistry International|May 14, 2017
Modifiable risk factors promoting neurodegeneration is associated with two novel brain degradation markers measured in serumJesper S Neergaard, Katrine Dragsbæk, Claus Christiansen, et al.
BMC Musculoskeletal Disorders|June 3, 2010
Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast qualityAnita V Neutzsky-Wulff, Mette G Sørensen, Dino Kocijancic, et al.
Obesity (Silver Spring, Md.)|June 15, 2016
The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesitySara Toftegaard Hjuler, Sofie Gydesen, Kim Vietz Andreassen, et al.
British Journal of Pharmacology|January 22, 2017
A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preferenceSofie Gydesen, Sara Toftegaard Hjuler, Zenia Freving, et al.
International Journal of Obesity (2005)|June 9, 2026
Dual amylin and calcitonin receptor agonists as multifaceted disease-modifying osteoarthritis drugsKhaled Elhady Mohamed, Anna Thorsø Larsen, Christian S Thudium, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Journal of Cachexia, Sarcopenia and Muscle|August 15, 2013
Type VI collagen turnover-related peptides-novel serological biomarkers of muscle mass and anabolic response to loading in young menAnders Nedergaard, Shu Sun, Morten A Karsdal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 6, 2025
Targeting the root cause of obesity-related comorbidities through weight independent and dependent actions on insulin sensitivity: Benefits of dual amylin and calcitonin receptor agonistsAnna Thorsø Larsen, Simone Anna Melander, Khaled Elhady Mohamed, et al.
Journal of Bone and Mineral Metabolism|December 26, 2006
Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral bloodMette Grøndahl Sørensen, Kim Henriksen, Sophie Schaller, et al.
Arthritis and Rheumatism|July 28, 2006
Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiationSvetlana Oestergaard, Bodil C Sondergaard, Pernille Hoegh-Andersen, et al.
The Journal of Biological Chemistry|August 23, 2003
Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expressionMorten A Karsdal, Pernille Hjorth, Kim Henriksen, et al.
Neurochemistry International|May 14, 2017
Modifiable risk factors promoting neurodegeneration is associated with two novel brain degradation markers measured in serumJesper S Neergaard, Katrine Dragsbæk, Claus Christiansen, et al.
BMC Musculoskeletal Disorders|June 3, 2010
Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast qualityAnita V Neutzsky-Wulff, Mette G Sørensen, Dino Kocijancic, et al.
Obesity (Silver Spring, Md.)|June 15, 2016
The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesitySara Toftegaard Hjuler, Sofie Gydesen, Kim Vietz Andreassen, et al.
British Journal of Pharmacology|January 22, 2017
A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preferenceSofie Gydesen, Sara Toftegaard Hjuler, Zenia Freving, et al.
International Journal of Obesity (2005)|June 9, 2026
Dual amylin and calcitonin receptor agonists as multifaceted disease-modifying osteoarthritis drugsKhaled Elhady Mohamed, Anna Thorsø Larsen, Christian S Thudium, et al.
Pageof 16